EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate

Lu Yu Kuo iD, Jenny Kuo iD, Joshua Silverman iD, Jason Jae Yeun Kim, Caitlin Letch, Scott McClintock

BJU International · 2024-12 · 134 (S2) · 30-37

DOI: 10.1111/bju.16478 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BJU International, online erschienen am 29.08.2024. Verfasst von Lu Yu Kuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Gold Coast University Hospital, Southport, Queensland, Australia. Hauptthemen laut MEDLINE: Transurethral Resection of Prostate, Prostatic Hyperplasia, Anticoagulants. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the perioperative morbidity and mortality associated with direct oral anticoagulants (DOACs) and warfarin for patients receiving transurethral resection of prostate (TURP). Patients and Methods This was a single‐centre, retrospective cohort analysis of patients who underwent TURP for benign prostate hyperplasia from April 2019 to December 2023. The primary objective was to evaluate the perioperative bleeding and thromboembolic risk between anticoagulated (AC) vs no‐AC patients. The secondary objective was to evaluate perioperative bleeding and thromboembolic risk between different formulations of DOACs. Patient demographics, prior treatment, prostate size, baseline bleeding risk, and operative details were collected. Bleeding and thromboembolic‐related morbidity were captured within a 3‐month postoperative period. Perioperative management of AC therapy was recorded, and all patients had their AC therapy withheld. Cohort characteristic between the AC vs no‐AC, and DOAC groups were analysed with two‐sided t ‐test, and chi‐square test. Further logistic regression analyses were carried out to identified significant variables between the groups. These significant variables were used for adjustment in inverse probability‐weighted treatment effect analysis to evaluate bleeding risk.

Results

There were 629 patients in the cohort, and 113 (18%) patients were receiving AC therapy. The AC patients were at 1.6 times statistically significant increased risk of acute bleeding, and 11 times increased risk of prolonged haematuria for >14 days. When compared to apixaban, patients on rivaroxaban conferred a statistically significant increased risk of acute bleeding by 2.21 times. Patients receiving AC therapy had a statistically significant increased risk of stroke in the perioperative setting (no‐AC vs AC: 0.4% vs 2.7%, P = 0.01).

Conclusion

This is the first study to evaluate risk of bleeding for TURP patients receiving DOACs. The AC patients are more likely to experience haematuria and stroke in the perioperative period despite withholding therapy. Apixaban appears to cause less bleeding‐related complications than rivaroxaban.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transurethral Resection of ProstateProstatic HyperplasiaAnticoagulantsHumansMaleRetrospective StudiesAgedMiddle AgedPostoperative HemorrhageWarfarinAdministration, OralPyridonesThromboembolismRivaroxabanPyrazolesAged, 80 and over

Stichwörter der Autor:innen

TURPanticoagulantapixabanbleedingrivaroxabantransurethral prostatectomy

Substanzen

AnticoagulantsWarfarinPyridonesapixabanRivaroxabanPyrazoles

Autor:innen und Institutionen

  • Department of Urology, Gold Coast University Hospital, Southport, Queensland, Australia.
  • School of Medicine and Dentistry, Griffith University, Southport, Queensland, Australia.

ORCID-Profile: Lu Yu Kuo, Jenny Kuo, Joshua Silverman

Zitieren

APA

Kuo, L. Y., Kuo, J., Silverman, J., Kim, J. J. Y., Letch, C., & McClintock, S. (2024). Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate. BJU International, 134(S2), 30-37. https://doi.org/10.1111/bju.16478

Vancouver

Kuo LY, Kuo J, Silverman J, Kim JJY, Letch C, McClintock S. Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate. BJU International. 2024;134(S2):30-37. doi:10.1111/bju.16478

BibTeX
@article{Kuo2024,
  author = {Kuo, Lu Yu and Kuo, Jenny and Silverman, Joshua and Kim, Jason Jae Yeun and Letch, Caitlin and McClintock, Scott},
  title = {Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate},
  journal = {BJU International},
  year = {2024},
  volume = {134},
  number = {S2},
  pages = {30--37},
  doi = {10.1111/bju.16478}
}
Kostenlos starten →